128 related articles for article (PubMed ID: 8175717)
21. Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells.
Graier WF; Myers PR; Rubin LJ; Adams HR; Parker JL
Circ Res; 1994 Oct; 75(4):659-68. PubMed ID: 7923612
[TBL] [Abstract][Full Text] [Related]
22. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
Flavahan NA
Am J Physiol; 1993 Mar; 264(3 Pt 2):H722-7. PubMed ID: 8456975
[TBL] [Abstract][Full Text] [Related]
24. Modulation of endothelial autacoid release by protein kinase C: feedback inhibition or non-specific attenuation of receptor-dependent cell activation?
Hecker M; Lückhoff A; Busse R
J Cell Physiol; 1993 Sep; 156(3):571-8. PubMed ID: 8103055
[TBL] [Abstract][Full Text] [Related]
25. Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism.
Berkenboom G; Langer I; Carpentier Y; Grosfils K; Fontaine J
Hypertension; 1997 Sep; 30(3 Pt 1):371-6. PubMed ID: 9314419
[TBL] [Abstract][Full Text] [Related]
26. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium.
Myers PR; Parker JL; Tanner MA; Adams HR
Shock; 1994 Jan; 1(1):73-8. PubMed ID: 7743332
[TBL] [Abstract][Full Text] [Related]
27. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH; Busse R
Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 mono-oxygenase-regulated signalling of Ca2+ entry in human and bovine endothelial cells.
Graier WF; Simecek S; Sturek M
J Physiol; 1995 Jan; 482 ( Pt 2)(Pt 2):259-74. PubMed ID: 7536247
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy enhances G protein activation and nitric oxide release from uterine arteries.
Thompson LP; Weiner CP
Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2069-75. PubMed ID: 11299208
[TBL] [Abstract][Full Text] [Related]
30. Cholera toxin augments the release of endothelium-derived relaxing factor evoked by bradykinin and the calcium ionophore A23187.
Boulanger CM; Vanhoutte PM
Gen Pharmacol; 1992 Jan; 23(1):27-31. PubMed ID: 1317311
[TBL] [Abstract][Full Text] [Related]
31. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells.
Ou Z; Ou J; Ackerman AW; Oldham KT; Pritchard KA
Circulation; 2003 Mar; 107(11):1520-4. PubMed ID: 12654610
[TBL] [Abstract][Full Text] [Related]
32. Membrane potential and Na(+)-K+ pump activity modulate resting and bradykinin-stimulated changes in cytosolic free calcium in cultured endothelial cells from bovine atria.
Laskey RE; Adams DJ; Johns A; Rubanyi GM; van Breemen C
J Biol Chem; 1990 Feb; 265(5):2613-9. PubMed ID: 2154452
[TBL] [Abstract][Full Text] [Related]
33. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH
Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
[TBL] [Abstract][Full Text] [Related]
34. Chronic exposure to high glucose impairs bradykinin-stimulated nitric oxide production by interfering with the phospholipase-C-implicated signalling pathway in endothelial cells: evidence for the involvement of protein kinase C.
Tang Y; Li GD
Diabetologia; 2004 Dec; 47(12):2093-104. PubMed ID: 15662551
[TBL] [Abstract][Full Text] [Related]
35. Interactions of bradykinin, calcium, G-protein and protein kinase in the activation of phospholipase A2 in bovine pulmonary artery endothelial cells.
Ricupero D; Taylor L; Polgar P
Agents Actions; 1993 Sep; 40(1-2):110-8. PubMed ID: 8147266
[TBL] [Abstract][Full Text] [Related]
36. Use-dependent loss of acetylcholine- and bradykinin-mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells.
Davisson RL; Bates JN; Johnson AK; Lewis SJ
Hypertension; 1996 Sep; 28(3):354-60. PubMed ID: 8794816
[TBL] [Abstract][Full Text] [Related]
37. Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s).
Boulanger C; Schini VB; Hendrickson H; Vanhoutte PM
Br J Pharmacol; 1990 Jan; 99(1):176-80. PubMed ID: 2158833
[TBL] [Abstract][Full Text] [Related]
38. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.
Parsaee H; McEwan JR; Joseph S; MacDermot J
Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of EDRF release by native low-density lipoprotein from cultured porcine endothelial cells through intracellular mechanisms.
Ezaki M; Ikeda M; Tomita I; Tomita T
J Cardiovasc Pharmacol; 1994 Oct; 24(4):552-8. PubMed ID: 7528837
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin and inositol 1,4,5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells.
Freay A; Johns A; Adams DJ; Ryan US; Van Breemen C
Pflugers Arch; 1989 Aug; 414(4):377-84. PubMed ID: 2798038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
